The Crystal Structure of Human Phosphoglucose Isomerase at 1.6 Å resolution:: Implications for catalytic mechanism, cytokine activity and haemolytic anaemia

被引:87
作者
Read, J
Pearce, J
Li, XC
Muirhead, H
Chirgwin, J
Davies, C
机构
[1] Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England
[2] Univ Bristol, Sch Med Sci, Bristol BS8 1TD, Avon, England
[3] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX 78229 USA
[4] Vet Adm Med Ctr, Res Serv, San Antonio, TX 78229 USA
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
aldose-ketose isomerases; neuroleukin; cytokine; haemolytic anaemia; X-ray crystallography;
D O I
10.1006/jmbi.2001.4680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphoglucose isomerase (PGI) is a multifunctional protein, which, inside the cell, functions as a housekeeping enzyme of glycolysis and gluconeogenesis and, outside the cell, exerts wholly unrelated cytokine properties. We have determined the structure of human PGI to a resolution of 1.6 Angstrom using X-ray crystallography. The structure is highly similar to other PGIs, especially the architecture of the active site. Fortuitous binding of a sulphate molecule from the crystallisation solution has facilitated an accurate description of the substrate phosphate-binding site. Comparison with both native and inhibitor-bound rabbit PCI structures shows that two loops move closer to the active site upon binding inhibitor. Interestingly, the human structure most closely resembles the inhibitor-bound structure, suggesting that binding of the phosphate moiety of the substrate may trigger this conformational change. We suggest a new mechanism for catalysis that uses Glu357 as the base catalyst for the isomerase reaction rather than His388 as proposed previously. The human PGI structure has also provided a detailed framework with which to map mutations associated with non-spherocytic haemolytic anaemia. (C) 2001 Academic Press.
引用
收藏
页码:447 / 463
页数:17
相关论文
共 70 条
[1]   GLUCOSE-6-PHOSPHATE ISOMERASE [J].
ACHARI, A ;
MARSHALL, SE ;
MUIRHEAD, H ;
PALMIERI, RH ;
NOLTMANN, EA .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1981, 293 (1063) :145-157
[2]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[3]   Study of the molecular defects in glucose phosphate isomerase-deficient patients affected by chronic hemolytic anemia [J].
Baronciani, L ;
Zanella, A ;
Bianchi, P ;
Zappa, M ;
Alfinito, F ;
Iolascon, A ;
Tannoia, N ;
Beutler, E ;
Sirchia, G .
BLOOD, 1996, 88 (06) :2306-2310
[4]   HEREDITARY HEMOLYTIC ANEMIA ASSOCIATED WITH GLUCOSEPHOSPHATE ISOMERASE (GPI) DEFICIENCY - A NEW ENZYME DEFECT OF HUMAN ERYTHROCYTES [J].
BAUGHAN, MA ;
VALENTINE, WN ;
PAGLIA, DE ;
WAYS, PO ;
SIMONS, ER ;
DEMARSH, QB .
BLOOD, 1968, 32 (02) :236-+
[5]   THE DIAGNOSTIC VALIDITY OF THE SERUM TUMOR-MARKER PHOSPHOHEXOSE ISOMERASE (PHI) IN PATIENTS WITH GASTROINTESTINAL, KIDNEY, AND BREAST-CANCER [J].
BAUMANN, M ;
KAPPL, A ;
LANG, T ;
BRAND, K ;
SIEGFRIED, W ;
PATEROK, E .
CANCER INVESTIGATION, 1990, 8 (3-4) :351-356
[6]   Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA) [J].
Beutler, E ;
West, C ;
Britton, HA ;
Harris, J ;
Forman, L .
BLOOD CELLS MOLECULES AND DISEASES, 1997, 23 (20) :402-409
[7]  
BLACKBURN MN, 1972, J BIOL CHEM, V247, P5668
[8]   MATRIX-BOUND PHOSPHOGLUCOSE ISOMERASE - FORMATION AND PROPERTIES OF PROPERTIES OF MONOMERS AND HYBRIDS [J].
BRUCH, P ;
SCHNACKERZ, KD ;
GRACY, RW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1976, 68 (01) :153-158
[9]  
BRUNGER AT, 1992, X PLOR VERSION 3 1 S, P3
[10]  
CAMPBELL JW, 1971, COLD SPRING HARB SYM, V36, P165